Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmesis Intl

0.400
0.000
Volume:- -
Turnover:- -
Market Cap:12.68M
PE:6.66
High:0.400
Open:0.400
Low:0.400
Close:0.400
52wk High:0.685
52wk Low:0.335
Shares:31.70M
Float Shares:6.77M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.060
EPS(LYR):0.051
ROE:18.14%
ROA:2.64%
PB:1.15
PE(LYR):7.87

Loading ...

Company Profile

Company Name:
Pharmesis Intl
Exchange:
SGX
Establishment Date:
1996
Employees:
1096
Office Location:
5 Kallang Sector,#03-02,Singapore,Singapore
Zip Code:
349279
Fax:
65 6743 7916
Introduction:
Pharmesis International Ltd. is a Singapore-based investment holding company. The Company is a pharmaceutical company engaged in the manufacturing of pharmaceutical products, including western medicine in the form of tablets and granules, among others, and traditional Chinese medicine (TCM) formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates in three segments: Western drugs, which refers mainly to chemically formulated drugs marketed under the Kinna brand; TCM formulated drugs, which includes TCM marketed under the Longlife brand, and Distribution, which includes agency products and internally manufactured products marketed through the distribution arm. Its main products are ATT, Gulin Gansu and Er Ding granules. Its subsidiary, Chengdu Kinna Pharmaceutical Co., Ltd, is engaged in the development, manufacture, packaging and sale of western medicines and health tonic products.